Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 25951 | 220 | 28.7 | 47% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1571 | 6700 | LEPROSY REVIEW//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES//LEPROSY |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CLOFAZIMINE | Author keyword | 17 | 37% | 17% | 37 |
| 2 | B669 | Author keyword | 8 | 100% | 2% | 5 |
| 3 | RIMINOPHENAZINES | Author keyword | 6 | 100% | 2% | 4 |
| 4 | CAS 2030 63 9 | Author keyword | 4 | 75% | 1% | 3 |
| 5 | ANTILEPROTICS | Author keyword | 3 | 100% | 1% | 3 |
| 6 | CLIN WARD INTERNAL DIS ANGIOL PHYS MED | Address | 1 | 100% | 1% | 2 |
| 7 | DIAGNOST LASER THER Y BYTOM | Address | 1 | 50% | 1% | 2 |
| 8 | MRC UNIT INFLAMMAT IMMUN | Address | 1 | 21% | 2% | 4 |
| 9 | INTRACELLULAR CRYSTALS | Author keyword | 1 | 33% | 1% | 2 |
| 10 | ANTITUBERCULOTIC | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CLOFAZIMINE | 17 | 37% | 17% | 37 | Search CLOFAZIMINE | Search CLOFAZIMINE |
| 2 | B669 | 8 | 100% | 2% | 5 | Search B669 | Search B669 |
| 3 | RIMINOPHENAZINES | 6 | 100% | 2% | 4 | Search RIMINOPHENAZINES | Search RIMINOPHENAZINES |
| 4 | CAS 2030 63 9 | 4 | 75% | 1% | 3 | Search CAS+2030+63+9 | Search CAS+2030+63+9 |
| 5 | ANTILEPROTICS | 3 | 100% | 1% | 3 | Search ANTILEPROTICS | Search ANTILEPROTICS |
| 6 | INTRACELLULAR CRYSTALS | 1 | 33% | 1% | 2 | Search INTRACELLULAR+CRYSTALS | Search INTRACELLULAR+CRYSTALS |
| 7 | ANTITUBERCULOTIC | 1 | 50% | 0% | 1 | Search ANTITUBERCULOTIC | Search ANTITUBERCULOTIC |
| 8 | CFZ | 1 | 50% | 0% | 1 | Search CFZ | Search CFZ |
| 9 | HCC CELL LINES | 1 | 50% | 0% | 1 | Search HCC+CELL+LINES | Search HCC+CELL+LINES |
| 10 | NOVIKOFF | 1 | 50% | 0% | 1 | Search NOVIKOFF | Search NOVIKOFF |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | B669 | 21 | 90% | 4% | 9 |
| 2 | LAMPRENE | 18 | 83% | 5% | 10 |
| 3 | B663 | 17 | 70% | 6% | 14 |
| 4 | PRO OXIDATIVE INTERACTIONS | 14 | 100% | 3% | 7 |
| 5 | RIMINOPHENAZINE AGENTS CLOFAZIMINE | 14 | 100% | 3% | 7 |
| 6 | B669 INHIBIT | 6 | 100% | 2% | 4 |
| 7 | TETRAMETHYLPIPERIDINE SUBSTITUTED PHENAZINES | 4 | 67% | 2% | 4 |
| 8 | RIMINOPHENAZINES | 4 | 75% | 1% | 3 |
| 9 | AGENTS CLOFAZIMINE | 3 | 100% | 1% | 3 |
| 10 | LYSOPHOSPHOLIPID DEPENDENT MECHANISM | 3 | 100% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Clofazimine: current status and future prospects | 2012 | 42 | 67 | 39% |
| Antimycobacterial activities of riminophenazines | 1999 | 71 | 40 | 45% |
| CLOFAZIMINE - A REVIEW OF ITS MEDICAL USES AND MECHANISMS OF ACTION | 1995 | 54 | 60 | 35% |
| Riminophenazine compounds: Pharmacology and anti-neoplastic potential | 1997 | 12 | 64 | 41% |
| CLINICAL PHARMACOKINETICS OF CLOFAZIMINE - A REVIEW | 1989 | 43 | 37 | 35% |
| CLOFAZIMINE - A REVIEW OF ITS USE IN LEPROSY AND MYCOBACTERIUM-AVIUM COMPLEX INFECTION | 1991 | 33 | 25 | 40% |
| A REVIEW OF SIDE-EFFECTS EXPERIENCED BY PATIENTS TAKING CLOFAZIMINE | 1983 | 20 | 1 | 100% |
| CLINICAL PHARMACOKINETIC CONSIDERATIONS IN THE TREATMENT OF PATIENTS WITH LEPROSY | 1989 | 20 | 39 | 28% |
| MAILLARD-REACTIONS OF THERAPEUTIC INTEREST | 1983 | 6 | 4 | 100% |
| Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents | 2009 | 27 | 52 | 4% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLIN WARD INTERNAL DIS ANGIOL PHYS MED | 1 | 100% | 0.9% | 2 |
| 2 | DIAGNOST LASER THER Y BYTOM | 1 | 50% | 0.9% | 2 |
| 3 | MRC UNIT INFLAMMAT IMMUN | 1 | 21% | 1.8% | 4 |
| 4 | BENJAMIN FRANKLIN UNIV CLIN | 1 | 50% | 0.5% | 1 |
| 5 | BIOCHEM NUCL MAGNET ONANCE CORE | 1 | 50% | 0.5% | 1 |
| 6 | BIOMED OURCES UNIT | 1 | 50% | 0.5% | 1 |
| 7 | IMMUNOLMED UNIT INFLAMMAT IMMUN | 1 | 50% | 0.5% | 1 |
| 8 | IMMUNOLMRCUNIT INFLAMMAT IMMUN | 1 | 50% | 0.5% | 1 |
| 9 | MED COUNCILUNIT INFLAMMAT IMMUN | 1 | 50% | 0.5% | 1 |
| 10 | DRUG METAB MAT MED | 0 | 33% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000209211 | ANTILEPROSY DRUGS//MYCOBACTERIUM LEPRAEMURIUM//INTRABACTERIAL NA K RATIO |
| 2 | 0.0000202076 | 1 AZABICYCLO330OCTANE//SK 946//PERHYDROPYRROLIZINE |
| 3 | 0.0000154602 | PYOCYANIN//PHENAZINES//1 HYDROXYPHENAZINE |
| 4 | 0.0000138747 | SI PHARMACOL TOXICOL//MICRONUCLEI INDUCED//TUBERCULOSIS CHEMOTHERAPY |
| 5 | 0.0000124976 | RIFABUTIN//KRM 1648//RIFALAZIL |
| 6 | 0.0000124536 | BC EPIDEMIOL INT OPHTHALMOL//OCULAR LEPROSY//HISTOPATHOL EXPT PATHOL |
| 7 | 0.0000121466 | EARLY BACTERICIDAL ACTIVITY//DELAMANID//BEDAQUILINE |
| 8 | 0.0000106498 | AMINOBENZYLATED MANNICH BASES//ANTI AGGREGATING AGENTS//AROMATIC DIAZONIUM SALT |
| 9 | 0.0000105236 | CYTOKINE BIOL SIGNAL TRANSDUCT//MICROGLIAL INFLAMMATION//MOUTH CLEANING |
| 10 | 0.0000092462 | LEPROSY REVIEW//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES//LEPROSY |